15-Apr-2026 Epigenetic dysregulation of PDX1 drives prostate cancer progression Impact Journals LLC Peer-Reviewed Publication
15-Apr-2026 From benign growth to pancreatic cancer: New study shows how the switch gets flipped Memorial Sloan Kettering Cancer Center Peer-Reviewed Publication
15-Apr-2026 Study reveals genome-wide host–virus genetic interactions in cancer risk Columbia University's Mailman School of Public Health Peer-Reviewed Publication
15-Apr-2026 “MitoCatch” delivers healthy mitochondria to diseased cells Institute of Molecular and Clinical Ophthalmology Basel Peer-Reviewed Publication
15-Apr-2026 Novel tool could identify new therapeutic targets in complex diseases like cancer Rockefeller University Peer-Reviewed Publication
15-Apr-2026 Large DRUP-trial sheds light on hidden potential of existing cancer drugs Netherlands Cancer Institute Peer-Reviewed Publication
15-Apr-2026 CRISPR variant selectively targets tumor DNA Van Andel Research Institute Peer-Reviewed Publication
15-Apr-2026 How do cancer cells ‘learn’ to resist treatment? NYU Langone Health / NYU Grossman School of Medicine Peer-Reviewed Publication
15-Apr-2026 Finding a hidden weakness inside cancer cells’ editing room Medical Research Council (MRC) Laboratory of Medical Sciences Peer-Reviewed Publication
15-Apr-2026 RBL LLC launches Duracyte, advancing living pharmacy platform in Houston’s growing biotech hub Rice University Business Announcement